Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens

RF Wang, X Wang, SL Johnston, G Zeng, PF Robbins… - Cancer research, 1998 - AACR
RF Wang, X Wang, SL Johnston, G Zeng, PF Robbins, SA Rosenberg
Cancer research, 1998AACR
A new retroviral system has been developed for the generation of a cDNA library and the
functional cloning of tumor antigens. These retroviral vectors contain a cytomegalovirus
promoter in the 5′ long terminal repeat, an extended packaging signal for rapid production
of high-titer retroviral particles, and many convenient cloning sites for cDNA library
construction. The vesicular stomatitis virus G protein has been used to generate pseudotype
retroviral particles to enable efficient viral infection. Using this system, viral titers in the range …
Abstract
A new retroviral system has been developed for the generation of a cDNA library and the functional cloning of tumor antigens. These retroviral vectors contain a cytomegalovirus promoter in the 5′ long terminal repeat, an extended packaging signal for rapid production of high-titer retroviral particles, and many convenient cloning sites for cDNA library construction. The vesicular stomatitis virus G protein has been used to generate pseudotype retroviral particles to enable efficient viral infection. Using this system, viral titers in the range of 106 colony-forming units/ml could be generated routinely, and a high transduction efficiency in human primary cells, including fibroblasts, was achieved. In addition, a new procedure has been devised for screening a retrovirus-based cDNA library without a functional selection. The utility of this system was demonstrated by constructing a retrovirus-based cDNA library and re-isolating the NY-ESO-1 tumor antigen from a cDNA library using an antigen-specific CTL. This approach can facilitate the identification of novel tumor antigens recognized by T cells without knowledge of MHC class I restriction elements and is generally applicable for the isolation of any gene as long as a biological assay is available.
AACR